Provided by Tiger Trade Technology Pte. Ltd.

Ligand Pharmaceuticals

183.98
-2.3400-1.26%
Post-market: 183.980.00000.00%16:35 EST
Volume:163.85K
Turnover:30.22M
Market Cap:3.62B
PE:81.05
High:186.55
Open:185.90
Low:182.51
Close:186.32
52wk High:212.49
52wk Low:93.58
Shares:19.68M
Float Shares:19.16M
Volume Ratio:0.98
T/O Rate:0.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.27
EPS(LYR):-0.2204
ROE:5.42%
ROA:1.48%
PB:3.81
PE(LYR):-834.57

Loading ...

Feb 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 18, 2025

Major Issues Report

Form 8-K - Current report
Dec 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 07, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Nov 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2025

Major Issues Report

Form 8-K - Current report
Sep 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Major Issues Report

Form 8-K - Current report
Aug 11, 2025

Major Issues Report

Form 8-K - Current report
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 07, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities